Crucell Holland B.v.

Jan H Ter Meulen

Edward Norbert Van Den Brink

Cornelis Adriaan De Kruif

Jaap Goudsmit

The present invention provides binding molecules that specifically bind to SARS-CoV, nucleic acid molecules encoding the binding molecules, compositions comprising the binding molecules and methods of identifying or producing the binding molecules. The binding molecules are capable of specifically binding to SARS-CoV and can be used in the diagnosis, prophylaxis and/or treatment of a condition resulting from SARS-CoV.

Growing community of inventors

Amsterdam, Netherlands

Jan H Ter Meulen